PetMed Express Inc (PETS) stock
PETSNasdaqRetail-Drug Stores and Proprietary StoresFiscal year ends March 31
Financials through Q2 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/3063% below fair value
$0.94−0.05 (-4.96%)
Close on Nov 13, 2026Market cap $20.38MP/E –Yield 0.00%
Earnings
PetMed Express's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
–
Not yet scheduled
Revenue, Q2 FY2027
$35.80M
Adjusted EPS, Q2 FY2027
-$0.31
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of PetMed Express's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q2 FY2027ended Sep 30, 2026 | Nov 10, 2026after the close | $35.80M | – | -$0.31 | – | Release |
| Q1 FY2027ended Jun 30, 2026 | Aug 13, 2026during market hours | $41.00M | – | -$0.28 | – | Release |
| Q4 FY2026ended Mar 31, 2026 | Jun 2, 2026during market hours | $42.80M | – | -$0.19 | – | Release |
| Q2 FY2026ended Sep 30, 2025 | Nov 13, 2025before the open | – | – | – | – | Release |
| Q4 FY2025ended Mar 31, 2025 | Jun 16, 2025before the open | – | – | – | – | Release |
| Q3 FY2025ended Dec 31, 2024 | Feb 10, 2025during market hours | $53.00M | -18.8% | -$0.03 | – | Release |
| Q2 FY2025ended Sep 30, 2024 | Nov 6, 2024during market hours | $59.60M | -16.1% | $0.11 | – | Release |
| Q1 FY2025ended Jun 30, 2024 | Aug 6, 2024during market hours | $68.00M | -13.0% | $0.18 | – | Release |
| Q4 FY2024ended Mar 31, 2024 | Jun 11, 2024during market hours | $66.50M | +6.6% | -$0.25 | – | Release |
| Q3 FY2024ended Dec 31, 2023 | Apr 15, 2024before the open | $65.30M | +10.9% | -$0.10 | – | Release |
| Q2 FY2024ended Sep 30, 2023 | Oct 30, 2023during market hours | $71.00M | +8.6% | $0.00 | – | Release |
| Q1 FY2024ended Jun 30, 2023 | Jul 31, 2023during market hours | $78.20M | +11.4% | -$0.04 | – | Release |
| Q4 FY2023ended Mar 31, 2023 | May 22, 2023during market hours | $62.40M | -5.5% | -$0.25 | – | Release |
| Q3 FY2023ended Dec 31, 2022 | Feb 6, 2023during market hours | $58.90M | -3.0% | $0.00 | $0.02 | Release |
| Q2 FY2023ended Sep 30, 2022 | Nov 7, 2022during market hours | $65.40M | -3.0% | $0.13 | – | Release |
| Q1 FY2023ended Jun 30, 2022 | Jul 26, 2022before the open | $70.20M | -11.5% | $0.14 | $0.31 | Release |
| Q4 FY2022ended Mar 31, 2022 | May 10, 2022during market hours | $66.00M | -7.9% | $0.30 | $0.47 | Release |
| Q3 FY2022ended Dec 31, 2021 | Jan 25, 2022during market hours | $60.70M | – | $0.21 | $0.37 | Release |
| Q2 FY2022ended Sep 30, 2021 | Oct 27, 2021before the open | $67.40M | – | $0.31 | – | Release |
| Q1 FY2022ended Jun 30, 2021 | Jul 27, 2021before the open | $79.30M | – | $0.22 | – | Release |
| Q4 FY2021ended Mar 31, 2021 | May 5, 2021during market hours | $71.70M | – | $0.34 | – | Release |
| Q3 FY2021ended Dec 31, 2020 | Jan 20, 2021during market hours | – | – | – | – | Release |
| Q2 FY2021ended Sep 30, 2020 | Oct 26, 2020during market hours | – | – | – | – | Release |
| Q1 FY2021ended Jun 30, 2020 | Jul 20, 2020during market hours | – | – | – | – | Release |
| Q4 FY2020ended Mar 31, 2020 | May 4, 2020during market hours | – | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
PetMed Express has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When PetMed Express puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases PetMed Express filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Update
- Results
- Update
- Results
- News
- Results
- Update
- Results
- Update
- Update
- Results
- Update
- Results
See a number that looks wrong?